BO ALLAIRE: Open Payments
NPI 1235363862 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 43 payments from 13 companies in 2025. Trend: 2023 $957 · 2024 $870 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 13 | $251 |
| Alkermes, Inc. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Braeburn Inc. | 3 | $67 |
| ABBVIE INC. | 3 | $64 |
| Lilly USA, LLC | 2 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
Products named: SUBLOCADE, VIVITROL, REXULTI, TRINTELLIX, Auvelity, BRIXADI, MOUNJARO, VRAYLAR.
Industry payments across TX — which companies pay providers there.
